Upload
christina-konrad
View
141
Download
0
Embed Size (px)
Citation preview
AimThis project aims to test the requirement of target genes of Id1 for the viability, self-renewal, and proliferation of cancer stem cells (CSCs). The aim is thus to test whether these candidates are potential therapeutic targets in triple negative breast cancer (TNBC) with the future perspective of developing targeted treatments.
Id1 expression system Id1 depletion system
RNA-Seq Gene Array
4267 9234Array dataId1 KD 4T1
RNA-seq dataId1+ C3Ttg
Bioinformaticanalyses
siRNA-mediated knockdown of target gene
Knockdown of taget gene affects self-renewal
Knockdown of taget gene does not affect self-renewal
Garvan Institute of Medical Research 384 Victoria Street Darlinghurst NSW 2010 Australia
Cancer Tumor Progression
Acknowledgements: This research is funded by the Cancer Counsel
NSW, Knud Højgaards Fond, Oticon Fonden, and Kræftens
Bekæmpelse.
Christina Konrad, Radhika Nair, Wee Teo, Kate Harvey, Daniel Roden, Ben Elsworth, Alexander Swarbrick The Kinghorn Cancer Centre & Cancer Research Division, Garvan Institute of Medical Research, Sydney
Deciphering the biology of Cancer Stem Cells in triple negative breast cancer
Candidate targets of Id1To characterise the network of genes regulated by Id1, bioinformatic analyses were performed on gene array or RNA-Seq data from two different TNBC models. 34 high confidence targets of Id1 were identified.
Validation of target genesThe requirement of these candidate genes for the viability, proliferation, and self-renewal of CSCs is currently being tested in vitro by knockdown studies using the tumorsphere and proliferation assays.
Id1 targets that are important for the CSC phenotype are potential therapeutic targets with the future prospect of developing targeted treatment for TNBC patients.
BackgroundWhile targeted treatments have resulted in a significant decrease in mortality rates for Hormone receptor and Her2 positive subtypes of breast cancer, no targeted treatment exist for patients with the aggressive triple negative breast cancer subtype. Malignant progression in TNBC is known to be driven by a subpopulation of tumor cells termed cancer stem cells (CSCs). Effective therapeutic targeting of CSCs is thus essential for the complete eradication of a tumor and prevention of relapse in patients due to outgrowth of chemo resistant CSCs. Research by our group has shown that the tran-scriptional repressor, Inhibitor of Differentation (Id1), is expressed within the CSCs of TNBC tumors and is important for the CSC phenotype like proliferation, self-renewal, and metastasis.
Knockdown of Id1/Id3 in a TNBC cell line model results in decreased cell proliferation.
Knockdown of Id1/Id3 reduces self-renewal in a TNBC cell line model.
Knockdown of Id1/Id3 suppresses spontaneous lung metastasis in mice.
Self-renewal
Metastasis
Proliferation
siRNA-mediated knockdown
Tumorsphere assayA key property of CSCs is their ability to self-renew. This property is tested in the tumorsphere assay in which cells are exposed to low adherent and non-differentiating conditions. Only cells with high self-renewal capacity are able to form tumorspheres under these conditions and thus have a phenotype associated with CSCs.
Possible outcomesTumorsphere assayLabeled cells
4T1 tumorsphere assay +/- methylcellulose
Num
bero
fprim
ary
tum
orsp
here
s/10
00ce
lls
0
20
40
60
80Labeled 4T1 cells+ methylcellulose
Labeled 4T1 cells- methylcellulose
Parental 4T1 cells+ methylcellulose
Parental 4T1 cells- methylcellulose
5000 10,000 5000 10,000 5000 10,000 5000 10,000
4T1 tumorsphere assay +/- methylcellulose
Num
bero
fsec
onda
rytu
mor
sphe
res/
1000
cells
0
20
40
60
80Labeled 4T1 cells+ methylcellulose
Labeled 4T1 cells- methylcellulose
Parental 4T1 cells+ methylcellulose
Parental 4T1 cells- methylcellulose
1000 5000 1000 5000 1000 5000 1000 5000
4T1 tumorsphere assay +/- methylcellulose
Num
bero
fsec
onda
rytu
mor
sphe
res/
1000
cells
0
20
40
60
80Labeled 4T1 cells+ methylcellulose
Labeled 4T1 cells- methylcellulose
Parental 4T1 cells+ methylcellulose
Parental 4T1 cells- methylcellulose
1000 5000 1000 5000 1000 5000 1000 5000
4T1 tumorsphere assay +/- methylcellulose
Num
bero
fsec
onda
rytu
mor
sphe
res/
1000
cells
0
20
40
60
80Labeled 4T1 cells+ methylcellulose
Labeled 4T1 cells- methylcellulose
Parental 4T1 cells+ methylcellulose
Parental 4T1 cells- methylcellulose
1000 5000 1000 5000 1000 5000 1000 5000
Defined shapeIrregular shape
- Methylcellulose + Methylcellulose- Methylcellulose + Methylcellulose
~100% aggregates ~50% aggregates
Seeding number
Methylcellulose
A lower seeding number reduced the number of aggregates. However, even at the lowest seeding number aggregates were formed.
Addition of 1% methylcellulose to the tumorsphere culture medium resulted in reduced aggregation and spheres with a more defined shape.
GFP
RFP
Tumorspheres formed at different seedingnumbers of MDA-MB-231 cells
MDA-MB-231 seeding number20
000
1500
010
000
5000
0
20
40
60
802000015000100005000
Num
ber
oftu
mor
sphe
res
Tumorspheres formed at different seedingnumbers of MDA-MB-231 cells
2000
015
000
1000
050
000
2
4
6
82000015000100005000
MDA-MB-231 seeding number
Num
ber
oftu
mor
sphe
res/
1000
cells
Optimization of tumorsphere assay